Trials / Unknown
UnknownNCT05703243
Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting ("DINOSAur II")
Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting. ("DINOSAur II")
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 572 (estimated)
- Sponsor
- Glendale Adventist Medical Center d/b/a Adventist Health Glendale · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To prospectively identify cancer patients whose tumors express specific molecular markers targeted by therapeutic agents from a comprehensive l i q u i d molecular test, for the purpose of selecting the most clinically appropriate treatment in a pragmatic two arm trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Comprehensive liquid molecular panel test | Lab test |
| OTHER | EORTC QLQ-30 | Quality of life questionnaire |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2024-01-01
- Completion
- 2025-01-01
- First posted
- 2023-01-27
- Last updated
- 2023-03-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05703243. Inclusion in this directory is not an endorsement.